Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes - Chakraborty, D; Maiti, A; Sheth, J U (Clin Ophthalmol, 2022)